Lupin submits New Drug Application for Etanercept biosimilar in Japan
Lupin submits New Drug Application for Etanercept biosimilar in Japan

Lupin submits New Drug Application for Etanercept biosimilar in Japan

Nikita Singh Article rating: 5.0

Pharma major Lupin announced on Tuesday that YL Biologics, its joint venture with Yoshindo and Kyowa in Japan has submitted a new drug application for marketing authorization to the Pharmaceuticals and Medical Devices Agency.

ICICI Bank jumps despite negative numbers
ICICI Bank jumps despite negative numbers

ICICI Bank jumps despite negative numbers

Rohan Takalkar Article rating: No rating

ICICI Bank, one of India's largest private sector banks, posted Q4FY18 and full year results on Monday. The NII for the quarter rose by 1 per cent in Q4FY18 vs Rs. 5,962 crore in Q4FY17. This minimal growth was largely due to higher interest expenses, which increased by 8 per cent yoy. The interest income for the quarter rose by 5.1 per cent yoy.


Maruti Suzuki calls back 50K units of Swift, Baleno
Maruti Suzuki calls back 50K units of Swift, Baleno

Maruti Suzuki calls back 50K units of Swift, Baleno

Gayathri Udyawar Article rating: 5.0

To inspect and replace a possible faulty part, auto major Maruti Suzuki has planned a service campaign starting next week. The fault is detected in the brake vacuum hose of the company's most popular UV brands.

MF Update: Mutual fund assets touch a new high in April 2018
MF Update: Mutual fund assets touch a new high in April 2018

MF Update: Mutual fund assets touch a new high in April 2018

Nikhil Desai Article rating: 5.0

The Indian mutual fund industry has kick-started its new financial year with robust AUM growth. Despite of the volatility in the Indian equity markets, assets under management of the industry rose by 1.37 lakh crore to reach its all-time high of Rs. 23.25 lakh crore as per AMFI data.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on May 8, 2018 opened gap up. BSE Sensex is trading at 35,288.23, up by 80.09 points and the Nifty is trading at 10,736.90, up by 21.40 points.

Lemon Tree Hotel sets aside Rs. 850 capex for expansion
Lemon Tree Hotel sets aside Rs. 850 capex for expansion

Lemon Tree Hotel sets aside Rs. 850 capex for expansion

Amir Shaikh Article rating: 5.0

Lemon Tree Hotels (LTH) is a fast growing chain of mid-priced hotels run by Indian hospitality industry's veterans. The company is India's third largest hotel chain on the basis of controlling interest in owned and leased rooms.

Indostar Capital Finance IPO
Indostar Capital Finance IPO

Indostar Capital Finance IPO

Sanket Dewarkar Article rating: 3.9

Yet another NBFC plans to hit the market and expects to raise ~Rs.1840 – 1844 crore. The IPO comprises a fresh issue of equity shares aggregating up to Rs. 700 crores and offer of sale of up to 2,00,00,000 equity shares in which Indostar Capital is the major promoter selling its stake of up to 1,85,08,407 shares.

Monsanto cannot enforce Bt cotton patent in India
Monsanto cannot enforce Bt cotton patent in India

Monsanto cannot enforce Bt cotton patent in India

Gayathri Udyawar Article rating: 2.5

In a landmark judgement, the Indian Supreme Court upheld the decision of Delhi High Court which refused to grant patent to the global agro-biotech major Monsanto for its GMO Bt. cotton seeds in India.

RSS
First33533354335533563358336033613362Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR